Enantioselective degradation of ofloxacin and levofloxacin by the bacterial strains Labrys portucalensis F11 (cas 19340-14-8) and Rhodococcus sp. FP1

Add time:08/07/2019    Source:sciencedirect.com

Fluoroquinolones are a class of antibiotics widely prescribed in both human and veterinary medicine of high environmental concern and characterized as environmental micropollutants due to their ecotoxicity and persistence and antibacterial resistance potential. Ofloxacin and levofloxacin are chiral fluoroquinolones commercialized as racemate and in enantiomerically pure form, respectively. Since the pharmacological properties and toxicity of the enantiomers may be very different, understanding the stereochemistry of these compounds should be a priority in environmental monitoring. This work presents the biodegradation of racemic ofloxacin and its (S)-enantiomer levofloxacin by the bacterial strains Labrys portucalensis F11 (cas 19340-14-8) and Rhodococcus sp. FP1 at a laboratory-scale microcosm following the removal and the behavior of the enantiomers. Strain F11 could degrade both antibiotics almost completely when acetate was supplied regularly to the cultures. Enrichment of the (R)-enantiomer was observed in FP1 and F11 cultures supplied with ofloxacin. Racemization was observed in the biodegradation of the pure (S)-ofloxacin (levofloxacin) by strain F11, which was confirmed by liquid chromatography - exact mass spectrometry. Biodegradation of ofloxacin at 450 µg L−1 by both bacterial strains expressed good linear fits (R2 > 0.98) according to the Rayleigh equation. The enantiomeric enrichment factors were comprised between − 22.5% to − 9.1%, and − 18.7% to − 9.0% in the biodegradation of ofloxacin by strains F11 and FP1, respectively, with no significant differences for the two bacteria under the same conditions. This is the first time that enantioselective biodegradation of ofloxacin and levofloxacin by single bacteria is reported.

We also recommend Trading Suppliers and Manufacturers of F11 (cas 19340-14-8). Pls Click Website Link as below: cas 19340-14-8 suppliers

Prev:Preclinical Analysis of JAA-F11 (cas 19340-14-8), a Specific Anti–Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging
Next:Pseudoginsenoside-F11 (cas 19340-14-8) alleviates cognitive deficits and Alzheimer’s disease-type pathologies in SAMP8 mice)